Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world

Journal of Clinical Oncology

Volumn 24, Issue 14, 2006, Pages 2137-2150

  Kamangar, Farin ^b   Dores, Graça M ^b   Anderson, William F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CIGARETTE SMOKING; COLON CANCER; DIET; ESOPHAGUS CANCER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE SYSTEM; HUMAN; LIVER CANCER; LUNG CANCER; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; REVIEW; RISK FACTOR; STOMACH CANCER; UTERINE CERVIX CANCER; ARTICLE; COST OF ILLNESS; HEALTH; HEALTH CARE DELIVERY; INCIDENCE; MORTALITY; NEOPLASM;

COST OF ILLNESS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; NEOPLASMS; PREVALENCE; RISK FACTORS; WORLD HEALTH;

EID: 33646568784     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.2308     Document Type: Review

References (193)

1. Trans-HHS Cancer Health Disparities Progress Review Group: Making cancer health disparities history. U.S. Department of Health and Human Services, 2004
2. Carter-Pokras O, Baquet C: What is a "health disparity"? Public Health Rep 117:426-434, 2002
3. Last JM: A Dictionary of Epidemiology (3rd Ed). Oxford, Oxford University Press, 1995
4. Ferlay J, Bray F, Pisani P, et al: GLOBOCAN 2002, Cancer incidence, mortality and prevalence worldwide, IARC CancerBase No. 5, version 2.0, IARC Press. Lyon, France. http://www-dep.iarc.fr/globocan/database.htm
5. Parkin DM, Whelan SL, Ferlay J, et al: Cancer incidence in five continents, Vol VIII. Lyon, France, IARC Scientific Publications No. 155, 2002
6. Armitage P, Doll R: A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer 11:161-169, 1957
7. Armitage P, Doll R: The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8:1-12, 1954
8. Devesa SS, Donaldson J, Fears T: Graphical presentation of trends in rates. Am J Epidemiol 141:300-304, 1995
9. Parkin DM, Whelan SL, Ferlay J, et al: Cancer incidence in five continents, I to VIII. Lyon, IARC Cancer Base No. 7, 2005
10. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005
11. Jemal A, Ward E, Thun MJ: Contemporary lung cancer trends among U.S. women. Cancer Epidemiol Biomarkers Prev 14:582-585, 2005
12. Bertram JS: The molecular biology of cancer. Mol Aspects Med 21:167-223, 2000
13. Ashley DJ: The two "hit" and multiple "hit" theories of carcinogenesis. Br J Cancer 23:313-328, 1969
14. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
15. Ezzati M, Lopez AD: Estimates of global mortality attributable to smoking in 2000. Lancet 362:847-852, 2003
16. Alberg AJ, Samet JM: Epidemiology of lung cancer. Chest 123:21S-49S, 2003
17. Wardwell NR, Massion PP: Novel strategies for the early detection and prevention of lung cancer. Semin Oncol 32:259-268, 2005
18. Alberg AJ, Brock MV, Samet JM: Epidemiology of lung cancer: Looking to the future. J Clin Oncol 23:3175-3185, 2005
19. Yang G, Fan L, Tan J, et al: Smoking in China: Findings of the 1996 National Prevalence Survey. JAMA 282:1247-1253, 1999
20. Warner KE: The role of research in international tobacco control. Am J Public Health 95:976-984, 2005
21. Ries LAG, Eisner MP, Kosary CL, et al: SEER Cancer Statistics Review, 1975-2002, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/ 1975_2002/sections.html
22. Hirsch FR, Lippman SM: Advances in the biology of lung cancer chemoprevention. J Clin Oncol 23:3186-3197, 2005
23. Mulshine JL: New developments in lung cancer screening. J Clin Oncol 23:3198-3202, 2005
24. Roemer R, Taylor A, Lariviere J: Origins of the WHO framework convention on tobacco control. Am J Public Health 95:936-938, 2005
25. WHO framework convention on tobacco control (WHA56.1), Fifty-six World Health Assembly (agenda item 13), 2003
26. Henderson BE, Feigelson HS: Hormonal carcinogenesis. Carcinogenesis 21:427-433, 2000
27. Lilienfeld AM, Johnson EA: The age distribution in female breast and genital cancers. Cancer 8:875-882, 1955
28. Clemmesen J: Carcinoma of the breast. Br J Radiol 21:583-590, 1948
29. Thomas DB: Breast cancer in men. Epidemiol Rev 15:220-231, 1993
30. Anderson WF, Althuis MD, Brinton LA, et al: Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83:77-86, 2004
31. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000: The global picture. Eur J Cancer 37:S4-66, 2001 (suppl 8)
32. Stevens RG, Moolgavkar SH, Lee JA: Temporal trends in breast cancer. Am J Epidemiol 115: 759-777, 1982
33. Anderson WF: Puberty and genetic susceptibility to breast cancer. N Engl J Med 349:1088-1089, 2003
34. Anderson WF, Chatterjee N, Ershler WB, et al: Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 76:27-36, 2002
35. Yasui Y, Potter JD: The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 10:431-437, 1999
36. Tarone RE, Chu KC: The greater impact of menopause on ER- than ER+ breast cancer incidence: A possible explanation (United States). Cancer Causes Control 13:7-14, 2002
37. Perou CM, Sorlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000
38. Moolgavkar SH, Lee JA, Hade RD: Comparison of age-specific mortality from breast cancer in males in the United States and Japan. J Natl Cancer Inst 60:1223-1225, 1978
39. Spratt JS Jr, Kaltenbach ML, Spratt JA: Cytokinetic definition of acute and chronic breast cancer. Cancer Res 37:226-230, 1977
40. Ershler WB: A gerontologist's perspective on cancer biology and treatment. Cancer Control 1:103-107, 1994
41. De Waard F, De Laive JWJ, Baanders-van Halewijn EA: On bimodal age distribution of mammary carcinoma. Br J Cancer 14:437-448, 1960
42. Anderson WF, Chu KC, Chang S, et al: Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 13:1128-1135, 2004
43. Stalsberg H, Thomas DB: Age distribution of histologic types of breast carcinoma. Int J Cancer 54:1-7, 1993
44. Stalsberg H, Thomas DB, Noonan EA: Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer 44:399-409, 1989
45. Putti TC, El-Rehim DM, Rakha EA, et al: Estrogen receptor-negative breast carcinomas: A review of morphology and immunophenotypical analysis. Mod Pathol 18:26-35, 2005
46. Armes JE, Egan AJ, Southey MC, et al: The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study. Cancer 83:2335-2345, 1998
47. Ashida A, Fukutomi T, Tsuda H, et al: Atypical medullary carcinoma of the breast with cartilaginous metaplasia in a patient with a BRCA1 germline mutation. Jpn J Clin Oncol 30:30-32, 2000
48. Hedenfalk I, Duggan D, Chen Y, et al: Gene-expression profiles in hereditary breast cancer. N Engl J Med 344:539-548, 2001
49. Breast Cancer Linkage Consortium: Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505-1510, 1997
50. Johannsson OT, Idvall I, Anderson C, et al: Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 33:362-371, 1997
51. Karp SE, Tonin PN, Begin LR, et al: Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 80:435-441, 1997
52. Lakhani SR, Gusterson BA, Jacquemier J, et al: The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6:782-789, 2000
53. Lakhani SR, Jacquemier J, Sloane JP, et al: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138-1145, 1998
54. Marcus JN, Page DL, Watson P, et al: BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer 80:543-556, 1997
55. Robson M, Gilewski T, Haas B, et al: BRCA-associated breast cancer in young women. J Clin Oncol 16:1642-1649, 1998
56. Verhoog LC, Brekelmans CT, Seynaeve C, et al: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351:316-321, 1998
57. Marcus JN, Watson P, Page DL, et al: Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709, 1996
58. Eisinger F, Jacquemier J, Charpin C, et al: Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res 58:1588-1592, 1998
59. Phillips KA: Breast carcinoma in carriers of BRCA1 or BRCA2 mutations: Implications of proposed distinct histologic phenotypes. Cancer 83: 2251-2254, 1998
60. Marcus JN, Watson P, Page DL, et al: BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat 44:275-277, 1997
61. Armes JE, Venter DJ: The pathology of inherited breast cancer. Pathology 34:309-314, 2002
62. Chabon AB, Takeuchi S, Sommers SC: Histologic differences in breast carcinoma of Japanese and American women. Cancer 33:1577-1579, 1974
63. MacMahon B, Morrison AS, Ackerman LV, et al: Histologic characteristics of breast cancer in Boston and Tokyo. Int J Cancer 11:338-344, 1973
64. Morrison AS, Black MM, Lowe CR, et al: Some international differences in histology and survival in breast cancer. Int J Cancer 11:261-267, 1973
65. Rosen PP, Ashikari R, Thaler H, et al: A comparative study of some pathologic features of mammary carcinoma in Tokyo, Japan and New York, USA. Cancer 39:429-434, 1977
66. Amaku EO: A review of 40 cases of breast cancer seen in Lagos Teaching Hospital. West Afr Med J Niger Pract 17:102-104, 1968
67. Klonoff-Cohen HS, Schaffroth LB, Edelstein SL, et al: Breast cancer histology in Caucasians, African Americans, Hispanics, Asians, and Pacific Islanders. Ethn Health 3:189-198, 1998
68. Lawson JS, Field AS, Tran DD, et al: Breast cancer incidence and estrogen receptor alpha in normal mammary tissue: An epidemiologic study among Japanese women in Japan and Hawaii. Int J Cancer 97:685-687, 2002
69. Blanks RG, Moss SM, McGahan CE, et al: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales. 1990-1998: Comparison of observed with predicted mortality. BMJ 321:665-669, 2000
70. Humphrey LL, Helfand M, Chan BK, et al: Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:347-360, 2002
71. Narod SA, Dube MP: Biologic characteristics of interval and screen-detected breast cancers, J Natl Cancer Inst 93:151-152, 2001
72. Porter PL, El-Bastawissi AY, Mandelson MT, et al: Breast tumor characteristics as predictors of mammographic detection: Comparison of interval-and screen-detected cancers. J Natl Cancer Inst 91:2020-2028, 1999
73. Gilliland FD, Joste N, Stauber PM, et al: Biologic characteristics of interval and screendetected breast cancers. J Natl Cancer Inst 92:743-749, 2000
74. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 90:1371-1388, 1998
75. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
76. Ries LAG, Eisner MP, Kosary CL, et al: SEER Cancer Statistics Review, 1975-2002, National Cancer Institute. Bethesda, MD, 2005
77. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1988
78. Day DW: The adenoma-carcinoma sequence. Scand J Gastroenterol Suppl 104:99-107, 1984
79. King H, Haenszel W: Cancer mortality among foreign- and native-born Chinese in the United States. J Chronic Dis 26:623-646, 1973
80. McMichael AJ, Giles GG: Cancer in migrants to Australia: Extending the descriptive epidemiological data. Cancer Res 48:751-756, 1988
81. McKeown-Eyssen GE: Fiber intake in different populations and colon cancer risk. Prev Med 16:532-539, 1987
82. Track B, Lanza E, Greenwald P: Dietary fiber, vegetables, and colon cancer: Critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 82:650-661, 1990
83. Slattery ML, Curtin KP, Edwards SL, et al: Plant foods, fiber, and rectal cancer. Am J Clin Nutr 79:274-281, 2004
84. Giovannucci E, Stampfer MJ, Colditz GA, et al: Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129:517-524, 1998
85. Chao A, Thun MJ, Connell CJ, et al: Meat consumption and risk of colorectal cancer. JAMA 293:172-182, 2005
86. Giovannucci E, Rimm EB, Stampfer MJ, et al: Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 54:2390-2397, 1994
87. Schatzkin A, Lanza E, Corle D, et al: Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342:1149-1155, 2000
88. Giovannucci E: Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 31:925-943, 2002
89. Giovannucci E: Diet, body weight, and colorectal cancer: A summary of the epidemiologic evidence. J Womens Health 12:173-182, 2003
90. Samad AK, Taylor RS, Marshall T, et al: A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 7:204-213, 2005
91. Schnohr P, Gronbaek M, Petersen L, et al: Physical activity in leisure-time and risk of cancer: 14-year follow-up of 28,000 Danish men and women. Scand J Public Health 33:244-249, 2005
92. Brown ML, Potosky AL: The presidential effect: The public health response to media coverage about Ronald Reagan's colon cancer episode. Public Opin Q 54:317-329, 1990
93. Smith RA, von Eschenbach AC, Wender R, et al: American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: Update 2001 - testing for early lung cancer detection. CA Cancer J Clin 51:38-75, 2001
94. Towler BP, Irwig L, Glasziou P, et al: Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev:CD001216, 2000
95. Kavanagh AM, Giovannucci EL, Fuchs CS, et al: Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 9:455-462, 1998
96. Muller AD, Sonnenberg A: Protection by endoscopy against death from colorectal cancer: A case-control study among veterans. Arch Intern Med 155:1741-1748, 1995
97. Muller AD, Sonnenberg A: Prevention of colorectal cancer by flexible endoscopy and polypectomy: A case-control study of 32,702 veterans. Ann Intern Med 123:904-910, 1995
98. Newcomb PA, Norfleet RG, Storer BE, et al: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84:1572-1575, 1992
99. Selby JV, Friedman GD, Quesenberry CP Jr, et al: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653-657, 1992
100. Hakama M, Hoff G, Kronborg O, et al: Screening for colorectal cancer. Acta Oncol 44:425-439, 2005
101. Hawk ET, Levin B: Colorectal cancer prevention. J Clin Oncol 23:378-391, 2005
102. Cunningham SC, Kamangar F, Kim MP, et al: Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution. J Gastrointest Surg 9:718-725, 2005
103. Faycal J, Bessaguet C, Nousbaum JB, et al: Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol 29:23-32, 2005
104. Tsubono Y, Hisamichi S: Screening for gastric cancer in Japan. Gastric Cancer 3:9-18, 2000
105. Roukos DH, Kappas AM: Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2:98-107, 2005
106. Helicobacter and Cancer Collaborative Group: Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347-353, 2001
107. Smith GD, Hart C, Blane D, et al: Adverse socioeconomic conditions in childhood and cause specific adult mortality: Prospective observational study. Bmj 316:1631-1635, 1998
108. van Loon AJ, Brug J, Goldbohm RA, et al: Differences in cancer incidence and mortality among socio-economic groups. Scand J Soc Med 23:110-120, 1995
109. Tredaniel J, Boffetta P, Buiatti E, et al: Tobacco smoking and gastric cancer: Review and meta-analysis. Int J Cancer 72:565-573, 1997
110. Buiatti E, Palli D, Decadi A, et al: A case-control study of gastric cancer and diet in Italy. Int J Cancer 44:611-616, 1989
111. De Stefani E, Correa P, Boffetta P, et al: Dietary patterns and risk of gastric cancer: A case-control study in Uruguay. Gastric Cancer 7:211-220, 2004
112. Nouraie M, Pietinen P, Kamangar F, et al: Fruits, vegetables, and antioxidants and risk of gastric cancer among male smokers. Cancer Epidemiol Biomarkers Prev 14:2087-2092, 2005
113. Munoz N, Franceschi S: Epidemiology of gastric cancer and perspectives for prevention. Salud Publica Mex 39:318-330, 1997
114. Blot WJ, Devesa SS, Kneller RW, et al: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289, 1991
115. Devesa SS, Fraumeni JF Jr: The rising incidence of gastric cardia cancer. J Natl Cancer Inst 91:747-749, 1999
116. Brown LM, Devesa SS: Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 11:235-256, 2002
117. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053, 1998
118. Engel LS, Chow WH, Vaughan TL, et al: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404-1413, 2003
119. Lindblad M, Rodriguez LA, Lagergren J: Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16:285-294, 2005
120. Lagergren J, Bergstrom R, Lindgren A, et al: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831, 1999
121. Dawsey SM, Mark SD, Taylor PR, et al: Gastric cancer and H pylori. Gut 51:457-458, 2002
122. Kolonel LN: Fat, meat, and prostate cancer. Epidemiol Rev 23:72-81, 2001
123. Chan JM, Gann PH, Giovannucci EL: Role of diet in prostate cancer development and progression. J Clin Oncol 23:8152-8160, 2005
124. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91: 608-612, 2003
125. Clark LC, Dalkin B, Krongrad A, et al: Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 81:730-734, 1998
126. Giovannucci E: The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 16:83-95, 2005
127. Viriamo J, Pietinen P, Huttunen JK, et al: Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up. JAMA 290:476485, 2003
128. Weinstein SJ, Wright ME, Pietinen P, et al: Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 97:396-399, 2005
129. Giovannucci E: A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med 227:852-859, 2002
130. Leitzmann MF, Stampfer MJ, Michaud DS, et al: Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 80:204-216, 2004
131. Freedland SJ: Obesity and prostate cancer: A growing problem. Clin Cancer Res 11:6763-6766, 2005
132. Haas GP, Sakr WA: Epidemiology of prostate cancer. CA Cancer J Clin 47:273-287, 1997
133. Breslow N, Chan CW, Dhom G, et al: Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 20:680-688, 1977
134. Harris R, Lohr KN: Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:917-929, 2002
135. Auvinen A, Curtis RE, Ron E: Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94:1330-1332, 2002
136. Kramer BS, Brown ML, Prorok PC, et al: Prostate cancer screening: What we know and what we need to know. Ann Intern Med 119:914-923, 1993
137. Lippman SM, Goodman PJ, Klein EA, et al: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 97:94-102, 2005
138. Lok AS: Prevention of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 127:S303-S309, 2004
139. Heathcote EJ: Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 127:S294-S302, 2004
140. Yu MC, Yuan JM: Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127:S72-S78, 2004
141. Morgan TR, Mandayam S, Jamal MM: Alcohol and hepatocellular carcinoma. Gastroenterology 127:S87-S96, 2004
142. Kowdley KV: Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127: S79-S86, 2004
143. Caldwell SH, Crespo DM, Kang HS, et al: Obesity and hepatocellular carcinoma. Gastroenterology 127:S97-S103, 2004
144. Powell EE, Jonsson JR, Clouston AD: Steatosis: Co-factor in other liver diseases. Hepatology 42:5-13, 2005
145. Jee SH, Ohrr H, Sull JW, et al: Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96:1851-1856, 2004
146. Schlesselman JJ: Net effect of oral contraceptive use on the risk of cancer in women in the United States. Obstet Gynecol 85:793-801, 1995
147. Sakoda LC, Graubard BI, Evans AA, et al: Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer 115:618-624, 2005
148. Bjelakovic G, Nikolova D, Simonetti RG, et al: Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev: CD004183, 2004
149. Seeff LB: Introduction: The burden of hepatocellular carcinoma. Gastroenterology 127:S1-4, 2004
150. Hoofnagle JH: Hepatocellular carcinoma: Summary and recommendations. Gastroenterology 127:S319-S323, 2004
151. World Health Organization. Hepatitis B vaccine, http://www.who.int/ vaccines/en/hepatitisb.shtml
152. Schiffman MH, Brinton LA, Devesa S, et al: Cervical cancer, in Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention. New York, Oxford University Press, 1996, pp 1090-1116
153. Bosch FX, de Sanjose S: Human papillomavirus and cervical cancer: Burden and assessment of causality, J Natl Cancer Inst Monogr 3-13, 2003
154. Munoz N, Bosch FX, de Sanjose S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527, 2003
155. Fasal E, Simmons ME, Kampert JB: Factors associated wih high and low risk of cervical neoplasia. J Natl Cancer Inst 66:631-636, 1981
156. Brinton LA, Hamman RF, Huggins GR, et al: Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 79:23-30, 1987
157. Hellberg D, Stendahl U: The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer. Anticancer Res 25:3041-3046, 2005
158. Castellsague X, Munoz N: Cofactors in human papillomavirus carcinogenesis: Role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 20-28, 2003
159. Ziegler RG, Weinstein SJ, Fears TR: Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. J Nutr 132:2345S-2349S, 2002
160. Hernandez BY, McDuffie K, Wilkens LR, et al: Diet and premalignant lesions of the cervix: Evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes Control 14:859-870, 2003
161. Schiffman M, Castle PE: The promise of global cervical-cancer prevention. N Engl J Med 353:2101-2104, 2005
162. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al: Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353:2158-2168, 2005
163. Zhou J, Sun XY, Stenzel DJ, et al: Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185:251-257, 1991
164. Koutsky LA, Ault KA, Wheeler CM, et al: A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645-1651, 2002
165. Villa LL, Costa RL, Petta CA, et al: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271-278, 2005
166. Stewart BW, Kleihues P: World Cancer Report. Lyon. IARC Press, 2003
167. Blot WJ, Li JY, Taylor PR, et al: Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85:1483-1492, 1993
168. Islami F, Kamangar F, Aghcheli K, et al: Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 90:1402-1406, 2004
169. Mahboubi E, Kmet J, Cook PJ, et al: Oesophageal cancer studies in the Caspian Littoral of Iran: The Caspian cancer registry. Br J Cancer 28:197-214, 1973
170. Somdyala NI, Marasas WF, Venter FS, et al: Cancer patterns in four districts of the Transkei region-1991-1995. S Afr Med J 93:144-148, 2003
171. Brown LM, Hoover RN, Greenberg RS, et al: Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst 86:1340-1345, 1994
172. Brown LM, Hoover R, Silverman D, et al: Excess incidence of squamous cell esophageal cancer among US black men: Role of social class and other risk factors. Am J Epidemiol 153:114-122, 2001
173. Tuyns AJ: Oesophageal cancer in non-smoking drinkers and in non-drinking smokers. Int J Cancer 32:443-444, 1983
174. Tran GD, Sun XD, Abnet CC, et al: Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113:456-463, 2005
175. Brown LM, Swanson CA, Gridley G, et al: Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States. Cancer Causes Control 9:467-474, 1998
176. Cook-Mozaffari PJ, Azordegan F, Day NE, et al: Oesophageal cancer studies in the Caspian Littoral of Iran: Results of a case-control study. Br J Cancer 39:293-309, 1979
177. Mark SD, Qiao YL, Dawsey SM, et al: Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92:1753-1763, 2000
178. Abnet CC, Lai B, Qiao YL, et al: Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst 97:301-306, 2005
179. Taylor PR, Qiao YL, Abnet CC, et al: Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 95:1414-1416, 2003
180. Kamangar F, Strickland PT, Pourshams A, et al: High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res 25:425-428, 2005
181. Abnet CC, Qiao YL, Mark SD, et al: Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control 12:847-854, 2001
182. Sepehr A, Kamangar F, Fahimi S, et al: Poor oral health as a risk factor for esophageal squamous dysplasia in northeastern Iran. Anticancer Res 25: 543-546, 2005
183. Vizcaino AP, Moreno V, Lambert R, et al: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99:860-868, 2002
184. Walther C, Zilling T, Perfekt R, et al: Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: A study of the Swedish population between 1970 and 1997. Eur J Surg 167:748-757, 2001
185. Wijnhoven BP, Louwman MW, Tilanus HW, et al: Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 14:115-122, 2002
186. Gammon MD, Schoenberg JB, Ahsan H, et al: Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89:1277-1284, 1997
187. Chow WH, Blot WJ, Vaughan TL, et al: Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90:150-155, 1998
188. Limburg PJ, Wei W, Ahnen DJ, et al: Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 129:863-873, 2005
189. Kresty LA, Morse MA, Morgan C, et al: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61:6112-6119, 2001
190. Shimizu M, Suzui M, Deguchi A, et al: Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells. Clin Cancer Res 10:1130-1140, 2004
191. Vaughan TL, Dong LM, Blount PL, et al: Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: A prospective study. http://oncology.thelancet.com, 2005
192. Raj A, Jankowski J: Acid suppression and chemoprevention in Barrett's oesophagus. Dig Dis 22:171-180, 2004
193. Danaei G, Vander Hoorn S, Lopez AD, et al: Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366:1784-1793, 2005